Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry

Introduction  Although guideline-adherent antithrombotic therapy (ATT) for stroke prevention in atrial fibrillation (AF) is associated with lower mortality and thromboembolism, ATT uptake shows geographic variation worldwide. We aimed to assess thromboembolic risk and baseline ATT by geographic regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazurek, Michał, Huisman, Menno V., Rothman, Kenneth J., Paquette, Miney, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J., Halperin, Jonathan L., Ma, Chang Sheng, Zint, Kristina, Elsaesser, Amelie, Lu, Shihai, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Schattauer GmbH 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260111/
https://www.ncbi.nlm.nih.gov/pubmed/29212125
http://dx.doi.org/10.1160/TH17-08-0555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260111/
https://www.ncbi.nlm.nih.gov/pubmed/29212125
http://dx.doi.org/10.1160/TH17-08-0555

Ejemplares similares